Imperva (IMPV) Getting Somewhat Favorable News Coverage, Accern Reports

Media stories about Imperva (NASDAQ:IMPV) have been trending somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imperva earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news coverage about the software maker an impact score of 45.9526908255538 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the news articles that may have impacted Accern Sentiment’s rankings:

How to Become a New Pot Stock Millionaire

Shares of NASDAQ:IMPV opened at $49.00 on Wednesday. The stock has a market cap of $1,733.34, a PE ratio of -175.00, a PEG ratio of 56.91 and a beta of 1.67. Imperva has a 12 month low of $37.17 and a 12 month high of $52.40.



Imperva (NASDAQ:IMPV) last issued its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the consensus estimate of $0.27 by $0.13. The firm had revenue of $91.10 million during the quarter, compared to the consensus estimate of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The company’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 earnings per share. sell-side analysts predict that Imperva will post 0.03 EPS for the current year.

Several research firms have issued reports on IMPV. BidaskClub upgraded shares of Imperva from a “hold” rating to a “buy” rating in a research report on Tuesday, April 17th. ValuEngine upgraded shares of Imperva from a “sell” rating to a “hold” rating in a research report on Thursday, February 15th. Piper Jaffray upgraded shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 price target for the company in a research report on Friday, February 9th. Morgan Stanley upped their price target on shares of Imperva from $37.00 to $39.00 and gave the company an “underweight” rating in a research report on Friday, February 9th. Finally, Imperial Capital upped their price target on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a research report on Friday, February 9th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $53.57.

In other news, CRO Michael D. Mooney sold 24,454 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the completion of the transaction, the executive now directly owns 24,454 shares of the company’s stock, valued at $1,153,739.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Anthony J. Bettencourt sold 66,037 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the transaction, the director now directly owns 66,037 shares of the company’s stock, valued at $3,102,418.26. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Imperva (IMPV) Getting Somewhat Favorable News Coverage, Accern Reports” was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://stocknewstimes.com/2018/04/25/imperva-impv-getting-somewhat-favorable-news-coverage-accern-reports.html.

About Imperva

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Insider Buying and Selling by Quarter for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply